American Diversified Holdings Corporation Biotech Alliance Partner INVENT Pharmaceuticals, Inc. Granted US Provisional Patent for Alzheimer's Drug

BioSpace Login

Enter your BioSpace account email address and password to log in now.

Email Address

Password

Keep me logged in

Close Window

Forgot Your Password? | Privacy Statement

NEW MEMBER SIGN UP

Display Name

Email Address

Password

Password again

Zip

Country

Close Window

Privacy Statement

Biotech and Pharmaceutical
News & Jobs

Search the Site

Community Login

What is this?

Employers
Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My eNewsletters

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

COMMUNITY
Login
Become a Member
Discussion Forums
FAQ

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

News | News By Subject | News by Disease | News By Date | Search News

American Diversified Holdings Corporation Biotech Alliance Partner INVENT Pharmaceuticals, Inc. Granted US Provisional Patent for Alzheimer's Drug
9/15/2009

DEL MAR, Calif.--(BUSINESS WIRE)--American Diversified Holdings Corporation (Pink Sheets: ADHC) Strategic Alliance partner INVENT Pharmaceuticals, Inc. announced today that the U.S. Patent and Trademark Office has granted its provisional patent application US 61/271,720 on novel drug candidates for the treatment of Alzheimer’s disease and age-related cognitive and memory impairment. Alzheimer’s disease is a progressive neurological disorder affecting nearly 37 million people worldwide. The estimated overall annual cost of patient care in the US alone is over $100 billion with over $5 billion in pharmaceutical costs. More than half of the individuals over age 85 and one in ten over age 65 will suffer from Alzheimer’s disease and related cognition and memory dysfunction. Alzheimer’s disease is the gradual loss of cognitive function related to memory, reasoning, judgment and orientation.

Read at BioSpace.com

• BioSpace.com

• American Diversified Holdings Corporation

• INVENT Pharmaceuticals, Inc.

• Biotech/Pharma - Patent News